What type of evidence is most robust for evaluating unlicensed medications for a rare condition?

• A. Animal studies
• B. Case reports
• C. Expert opinion
• D. Systematic reviews

Answer: (D)

Systematic reviews synthesize all available data on a topic using a predefined search strategy and explicit inclusion criteria, then critically appraise and, if possible, combine the findings. This structured approach reduces bias and provides a transparent, comprehensive assessment of what is known about unlicensed medications for a rare condition. In rare conditions, individual studies are often small, inconsistent, or absent; a single case report or animal study can be misleading when applied to humans. By aggregating and evaluating multiple sources—while judging the quality of each piece of evidence—the review offers the most reliable overall picture, including what is known about safety and effectiveness and where uncertainty remains. Other options, such as animal studies (preclinical) or expert opinion (individual judgment), lack direct human applicability or systematic evaluation, and case reports, while informative, are limited by anecdotal nature.